We are live on ! Find out more
CKPT

Checkpoint Therapeutics
CKPT

Delisted

CKPT was delisted on the 29th of May, 2025.

Back to rankings

62 hedge funds and large institutions have $30.7M invested in Checkpoint Therapeutics in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

263% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 8

113% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 8

17% more funds holding

Funds holding: 53 → 62 (+9)

0.14% less ownership

Funds ownership: 2.12% → 1.98% (-0.14%)

10% less capital invested

Capital invested by funds: $34M → $30.7M (-$3.37M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
62
Holders Change
+9
Holders Change %
+16.98%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
17
Increased
29
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.24M
2
TI
tru Independence
Oregon
+$1.1M
3
Millennium Management
Millennium Management
New York
+$693K
4
BlackRock
BlackRock
New York
+$433K
5
Two Sigma Investments
Two Sigma Investments
New York
+$364K

Top Sellers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
-$5.02M
2
SM
Sabby Management
Florida
-$2.5M
3
Renaissance Technologies
Renaissance Technologies
New York
-$227K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$214K
5
TRCT
Tower Research Capital (TRC)
New York
-$96.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
FAM
26
Fenimore Asset Management
New York
$86K – – –
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$82K – – –
RhumbLine Advisers
28
RhumbLine Advisers
Massachusetts
$81K +$12.7K +500 +20%
Renaissance Technologies
29
Renaissance Technologies
New York
$74K -$227K -8,985 -76%
Manulife (Manufacturers Life Insurance)
30
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$72K +$1.24K +49 +2%
Invesco
31
Invesco
Georgia
$66K +$63.5K +2,509 New
PPA
32
Parametric Portfolio Associates
Washington
$63K +$14.1K +556 +30%
VOYA Investment Management
33
VOYA Investment Management
Georgia
$57K +$17.8K +705 +48%
VF
34
Virtu Financial
New York
$56K -$23.1K -914 -30%
Bank of America
35
Bank of America
North Carolina
$54K +$41.4K +1,635 +391%
SSA
36
Schonfeld Strategic Advisors
New York
$53K +$50.6K +2,000 New
TC
37
Tatro Capital
Kentucky
$49K +$46.5K +1,836 New
Two Sigma Advisers
38
Two Sigma Advisers
New York
$46K +$44K +1,740 New
Barclays
39
Barclays
United Kingdom
$44K -$9.92K -392 -19%
FAIM
40
Financial Advocates Investment Management
Washington
$40K +$38K +1,500 New
N
41
Natixis
France
$40K +$38K +1,500 New
CS
42
Credit Suisse
Switzerland
$38K +$36.1K +1,425 New
Jane Street
43
Jane Street
New York
$37K +$34.9K +1,378 New
Principal Financial Group
44
Principal Financial Group
Iowa
$35K +$33.3K +1,314 New
Envestnet Asset Management
45
Envestnet Asset Management
Illinois
$31K +$30K +1,184 New
ProShare Advisors
46
ProShare Advisors
Maryland
$30K +$28.9K +1,144 New
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$29.3K -$18.1K -717 -39%
Truist Financial
48
Truist Financial
North Carolina
$29K +$2K +79 +8%
Squarepoint
49
Squarepoint
New York
$28K +$27.1K +1,070 New
UBS Group
50
UBS Group
Switzerland
$27K +$25.1K +993 +3,678%
1
2
3

CKPT Hedge Fund Activity: Q4 2020 in Review

62 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q4 2020, worth a combined $30.7M — down 9.9% from $34M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CKPT positions and 8 closed out — a net gain of 9 holders — while 29 added to existing stakes and 8 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $1.24M. The largest seller was CVI Holdings, cutting an estimated $5.02M.

  • 62 institutional investors held Checkpoint Therapeutics (CKPT) as of Q4 2020, up from 53 in Q3 2020.
  • Funds reported $30.7M of Checkpoint Therapeutics stock for Q4 2020, down 9.9% quarter-over-quarter.
  • 17 funds opened new Checkpoint Therapeutics positions in Q4 2020 and 8 closed out, a net change of +9 holders.
  • The largest Checkpoint Therapeutics buyer in Q4 2020 was Morgan Stanley, an estimated $1.24M added.
  • The largest Checkpoint Therapeutics seller in Q4 2020 was CVI Holdings, an estimated $5.02M sold.

Based on aggregated 13F filings for Q4 2020.